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Abstract This study investigated cryopreserved
pulmonary homograft (CPA) structural integrity after
prolonged cold ischemic harvesting times in a juvenile
sheep model. Three groups with different post-mortem
cold ischemic harvesting times were studied, i.e.
Group 1 (24 h, n = 10); group 2 (48 h, n = 10);
group 3 (72 h, n = 10). In each group, 5 CPAs were
studied in vitro after cryopreservation and thawing.
The other 5 CPAs were implanted in juvenile sheep for
a minimum of 180 days. Serology samples were
obtained and echocardiography was performed before
euthanasia. Hematoxylin and eosin (H&E), scanning
electron microscopy (SEM), von Kossa, Picrosirius
red, a-actin, immunohistochemistry [von Willebrand
factor (vWF), CD4, CD31 and CD34] and calcium
content analyses were performed on explanted CPAs.
The in vitro and in vivo studies failed to demonstrate
any change in tensile strength, Young’s Modulus and
thermal denaturation (Td) results between the groups.
SEM demonstrated a reduction in endothelial cells
(50 % at 24 h, 60.9 % at 48 h and 40.9 % at 72 h), but
H&E could not demonstrate autolysis in any CPA
in vitro. All cultures were negative. In the explanted
groups, IgE, IgM and IgG results were inconclusive.
Echocardiography demonstrated normal valve func-
tion in all groups. H&E and Picrosirius red staining
confirmed tissue integrity. vWF, CD31 and CD34
staining confirmed a monolayer of endothelial cells in
all explanted valves. Calcium content of explanted
CPA leaflets was similar. This experimental study
supports the concept of prolonging the cold ischemic
harvesting time of cryopreserved homografts to reduce
homograft shortage.
Keywords Cryopreserved homografts  Warm
ischemic time  Right ventricular outflow tract
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Introduction
The gold standard for reconstruction of the right
ventricular outflow tract (RVOT) is cryopreserved
pulmonary homografts (CPAs). Although Chambers
et al. (1997) showed that freedom from reoperation
following homograft reconstruction of the RVOT
using the Ross procedure to be as high as 80 % at
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25 years of follow-up, it is generally agreed that
homografts degenerate over time. This degeneration is
mostly due to immune responses (Welters et al. 2002;
Neumann et al. 2014). Alternatives to homografts are
xenogenic heart valves, which are available off-the-
shelf. However, these valves are treated with glu-
taraldehyde and therefore present serious limitations
for young patients due to early tissue degeneration and
calcification (Holmes et al. 2012; Homann et al. 2000).
A further alternative is tissue engineered pulmonary
heart valves which show promising results for up to
10 years if the scaffold is a homograft (Dohmen et al.
2011; Cebotari et al. 2011). Since CPA use is limited
by donor availability, especially with respect to small
valve sizes, investigations are needed to increase the
pool of potentially available human heart valves
without compromising quality. The international norm
for harvesting valves either from heart transplant
recipients, beating heart donors or non-beating heart
donors, is limited to 24 h post-mortem. The reason for
this restraint is that increased homograft durability
was demonstrated with retained cellular viability in
cryopreserved homografts (Angell et al. 1989;
O’Brien et al. 1995). However, Mitchell et al. (1998)
argue that most homografts are acellular and that
valvular performance is linked to retention of struc-
tural integrity of the valve scaffold and not cellular
viability.
This study investigated CPA structural integrity
after prolonged cold ischemic harvesting times in a
juvenile sheep model.
Materials and methods
All animal experiments and surgical procedures were
performed in compliance with the Guide for the Care
and Use of Laboratory Animals as published by the US
National Institutes of Health (NIH Publication 85-23,
revised 1996). Approval of the study protocol was
obtained from the Animal Ethics Committee of the
University of the Free State (ETOVS nr. 12/06). A
schematic presentation of the study layout is provided
in Fig. 1.
Three groups with different post-mortem cold
ischemic harvesting times were studied in vitro as
well as in vivo, while a fourth group with valves
(n = 5) harvested within 6 h post-mortem and non-
cryopreserved, were used as control in the in vitro
studies: group 1 (24 h, n = 10); group 2 (48 h,
n = 10); group 3 (72 h, n = 10). In each of the three
groups, 5 CPAs were studied in vitro after processing
and thawing to evaluate tissue integrity and impact of
processing. The other 5 CPAs from each group were
studied in vivo through implantation in juvenile sheep,
for a minimum of 180 days (group 1: n˜ = 210 days;
group 2: n˜ = 206 days; group 3: n˜ = 188 days), to
evaluate valve performance, biological interaction and
modes of degeneration. The population median values
between the different days of implantation in the three
groups proved not to differ significantly (p[ 0.05)
from each other. Wethers of the Dorper strain were
used and each carcass and recipient animal received an
ear tag with a unique identification number.
Pulmonary valve harvesting and preparation
For the control group, hearts were obtained from a
local abattoir directly after slaughtering and transport-
ed on ice to the laboratory. The valves were dissected
and washed in cold (4 C) Ringers-lactate (Bodene
Pty, Ltd trading as Intramed, Port Elizabeth, SA) and
all required samples taken for evaluation. For the other
three groups, thirty juvenile sheep were sacrificed by
intravenous injection of an overdose of potassium
chloride (Adcock Ingram Critical Care, Johannesburg)
and pulmonary valve conduits for the preparation of
cryopreserved ovine homografts were harvested at 24,
48 and 72 h respectively. Ischemic time was defined as
the time between death and harvesting of the heart
valve. Ischemic time was composed of a 6 h period of
warm ischemia (from death to refrigeration of the
cadaver in the mortuary) followed by a longer period
of cold ischemia until the heart was removed from the
cadaver at the designated times. The carcasses were
skinned after euthanasia and the large stomach was
removed to limit the effect of the ongoing intestinal
fermentation process, which is typical in ruminants
and would increase the body temperature and subse-
quently the rate of autolysis. In group 1 (n = 5) the
pulmonary heart valves were removed as a valve
conduit and processed after 24 h, in group 2 (n = 5)
after 48 h and in group 3 (n = 5) after 72 h. The
valves were rinsed, inspected for fenestrations or other
abnormalities and the thickness of the myocardium
was trimmed to approximately 5 mm. A competency
test was performed to evaluate regurgitation control.
Each valve was immersed in 100 ml of M199 with
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Earle’s Base (Highveld Biological (Pty) Ltd., Johan-
nesburg, South Africa (SA) containing 2.5 mg Fungi-
zone (Bristol-Meyers Squibb, Johannesburg, SA),
25 mg Amikacin (Fresenius, Bodene (Pty) Limited
trading as Intramed, Johannesburg, SA), 50 mg
Cefoxitin (Sabax, Johannesburg, SA) and 50 mg
Piperacillin (Sabax, Johannesburg, SA) to sterilize
for 24 h. Then the pulmonary valves were cryopre-
served under sterile conditions using a Cryoson BV-9
Biological Freezer (Consarctic, Scho¨llkrippen, Ger-
many). Valves were placed in a cryobag containing a
solution of 100 ml M199 with 11 ml dimethylsulfox-
ide (DMSO) and cryopreserved at a rate of ap-
proximately -1 C/min until -140 C was reached.
Quality control for the cryopreservation of the heart
valves procured for this study was performed accord-
ing to ISO 9000 standards.
Cryopreserved valves were stored in the vapor
phase of liquid nitrogen (LN2) for a minimum period
of 2 weeks till implantation. At thawing, the cryobags
were placed on a shelf at room temperature for±5 min
to eliminate the excessive cold temperature, followed
by immersion in a waterbath at 30 C for another
5–7 min until most of the liquid inside the bag have
melted. The bag was then opened sterile and the
contents placed gently in two changes of 500 ml of
M199 at 4 C for 10 min each, before implantation.
In vitro study
Biomechanical testing
Biomechanical properties of the tissue samples were
examined using a tensile testing apparatus (Lloyds
LS100 Plus tensile strength (TS) tester, IMP, Johan-
nesburg, SA). TS and YM were performed on tissue
samples fixated with clamps at both ends and
gradually stretched (0.1 mm/s) by applying constant
tension on the ends (Thubrikar et al. 1983). Both
pulmonary valve leaflets and wall samples underwent
biomechanical testing.
Determination of Thermal Denaturation Tem-
perature (Td) is a technique for thermal analysis,
performed using differential scanning calorimetry
(DSC) (Mettler Toledo, DSC 822e, Microsep, Johan-
nesburg, SA). In DSC, the rate of heat flow to the
sample is compared to the rate of heat flow to an inert
material, while the materials are heated or cooled
concurrently. For proteins, the thermally induced
process detectable by DSC is the structural malting
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Fig. 1 Outline of the study
methodology
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or unfolding of the molecule. The transition of protein
from a native to a denatured conformation is accom-
panied by the rupture of inter- and intra-molecular
bonds, and the process has to occur in a cooperative
manner to be discerned by DSC (Smith and Judge
1991). This was recorded as Td for each group (Ru¨egg
et al. 1975).
Microbiological examinations
Blood culture samples were taken intra-cardially from
each intact donor heart before harvesting the heart for
further dissection of the valves (groups 1–3). These
samples were analyzed using standard microbiological
techniques for detecting aerobic and anaerobic mi-
crobes, as well as for fungi. At cryopreservation, tissue
and fluid samples from each valve were also taken for
microbiological testing, and compared to the organ-
isms cultured from blood samples taken intra-cardially
at harvesting.
Histological evaluation
Specimens, for light microscopy examination, were
taken from the middle of the pulmonary leaflet of each
CPA as well as the wall of each CPA. These specimens
were embedded in paraffin wax and two micrometer
thick longitudinal sections were then prepared and
routinely processed with H&E, von Kossa and
Picrosirius red stainings. Specimen numbers were
randomly allocated to each tissue sample, allowing
completely blinded evaluation by all the evaluators for
histology, immunohistochemistry and scanning elec-
tron microscopy (SEM) samples.
Immunohistochemistry
Immunohistochemical staining was performed with
anti-von Willebrand factor (vWF) rabbit polyclonal
antibody (Abcam, Cambridge, United Kingdom (UK),
anti-CD4 rabbit polyclonal antibody (Bioss, Atlanta,
United States of America (USA), anti-CD31 mouse
monoclonal antibody (Abcam, Cambridge, UK), anti-
CD34 goat polyclonal antibody (Santa Cruz Biotech-
nology Inc, Dallas, Texas, USA) and anti-a-smooth
muscle actin rabbit polyclonal antibody (Abcam,
Cambridge, UK). Different valvular regions were
investigated, due to differing shear stresses at the
leaflets compared with the rest of the valves. From
each region representative samples were obtained
including the inflow and outflow aspects of the valve.
Scanning electron microscopy
All valves were fixed in 2.5 % Glutaraldehyde (Mer-
ck, Johannesburg, SA). Valve leaflets were divided
into two specimens of approximately 3 9 6 mm.
Similar specimen samples were taken from the
pulmonary wall, sinus area and pulmonary trunk.
Tissue specimens were dried using the critical point
method and were metalized using gold.
Evaluations were performed with a Shimadzu SSX
550 scanning electron microscope (Kyoto, Japan). The
surface area of each specimen was examined and
photographed at either four or five different positions,
and all images were then evaluated by three independent
evaluators and a score allocated. An average score for
each specimen was then calculated. A three category
scoring system, adapted from the six categories de-
scribed by Krs et al. (2006) was used to define
endothelial integrity and to evaluate the quality of the
extracellular matrix (ECM) surface area. The classifi-
cation of tissue was based on two key markers,
endothelium and basal membrane. Category I; there is
a virtual absence of both endothelium and basal
membrane and the bare scaffold of the tissue is exposed.
Category II; the basal membrane predominantly covers
the scaffold and the endothelium is largely missing.
Category III; the endothelium is virtually intact.
In vivo study
Echocardiography
Hemodynamic evaluation was performed by one expe-
rienced investigator using trans-thoracic echocar-
diography prior to sacrifice. A Philips Envisor Ultra
Sound system (Philips, Johannesburg, SA) was used
with a 3.5-MHz probe and all data were recorded. Two-
dimensional trans-thoracic echocardiography was per-
formed to evaluate morphological conditions of the
valve conduit and leaflets. Additionally, the diameters
of the valve annulus, sinotubular junction (ST-junction)
and pulmonary artery wall were measured. Pulmonary
insufficiency was evaluated semi-quantitatively using
pulsed wave, continuous wave and color Doppler flow
on the parasternal short axis view. The regurgitation jet
across the valve was graded by identification length and
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width into the right ventricular outflow tract and
mapped as: none/trivial, mild, moderate or severe using
standard echocardiography criteria. The mean flow
velocities across the implanted valves were obtained by
the use of continuous wave Doppler. Each measure-
ment was repeated six times and the mean value over
the measurements was calculated. Again animals were
only identified by their individual ear tag numbers,
allowing blinded evaluation by the sonographer.
Serology samples
Full blood counts were analyzed on a Sysmex XE
2100 (Roche, Johannesburg, SA) according to the TF/
DC detection method, hydrodynamic focusing (DC
detection), flow cytometry method and a SLS-he-
moglobin method. Immunoglobulins (IgG, IgA and
IgM) in serum were determined quantitatively by
means of immunonephelometry on a Siemens BN
ProSpec Nephelometer (Siemens, Johannesburg, SA).
Gross examination
The explanted CPAs were inspected and color
photographs were taken before fixation. The leaflets
were inspected for fenestrations, retraction, throm-
botic material, atheroma and calcification.
Calcium content analysis
Quantitative calcium analyses were performed on
samples dried in a temperature controlled Scientific
series 100 incubator (Lasec, Johannesburg, SA) at
45 C for 48 h. Samples were weighed and hy-
drolyzed in 1 ml 50 % nitric acid and 50 ll hydrogen
peroxide. Extractable calcium content was determined
by inductively coupled plasma mass spectrometry
Agilent ICP-MS 7500c (Chemetrix, Midrand, SA) and
expressed as lg calcium per mg dry weight tissue.
Only calcium content of the pulmonary leaflet and
wall of the control group (\6 h) were determined pre-
implantation and used as baseline values, and com-
pared to the explanted tissues of the three ischemic
groups.
Statistical analysis
For statistical analysis purposes, the cold ischemic time
was described by the time effect and the source of a
sample, i.e., whether the sample was sourced from the
aortic leaflet or the aortic wall, was described by the
source effect. Various measurements (Td, Calcium,
etc.) were analyzed separately using linear models in
order to determine whether there were significant time
or source effects and whether there was an interaction
between time and source. Time and source were treated
as simple fixed effects and an interaction effect was also
considered. Standard ANOVAs were also done over
time and over source to obtain additional clues as to
whether either effect was significant. The study was not
statistically powered to detect differences due to the
cost restraints involved.
Where the interaction effect in the linear model was
significant, further investigation was done using
ANOVA methods by separating the sources. In a few
significant cases (where the time effect was significant
for a specific source) the results were investigated even
more deeply using Welch Two Sample t tests. This
involved comparing the three timestamps in pairs. This
top-down approach (starting global and drilling down)
was followed throughout in order to avoid spurious
results and false positives/negatives.
Where the above method was not appropriate, other
methods were applied. For example, the sonar data
was analyzed using Hotelling’s test and the SEM data
was analyzed with Pearson’s Chi Square test. For
Hotelling’s test we have to assume multivariate
normality as the sample size is too small to conduct
tests for this.
Surgical implantation
The juvenile sheep were male with a mean age of
4–6 months and a mean body weight of 34–40 kg.
Premedication was administered with 0.175 mg/kg
Neurotranq [VirbacRSA (Pty) Ltd, Halfway House,
SA] and 0.2 mg/kg Atropine [Bayer (Pty) Ltd, Animal
Health Division, Isando, SA] intramuscularly, and
anesthesia was induced with 12 mg/kg Bomathal
[Merial SA (Pty) Ltd, Halfway House, SA] intra-
venously. The sheep were intubated, ventilated and
positioned in a lateral decubitus position. Arterial
cannulation for cardiopulmonary bypass was obtained
via the left carotid artery. The stump pressure of the
tied-off distal carotid artery was used for invasive
arterial pressure measurement. A left mini-thoracoto-
my was performed and the fourth rib removed. The
pulmonary artery was transected and the native
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pulmonary valve leaflets were excised. The CPAs,
with a diameter of ±16 mm, were implanted as an
interposition, with two continuous 4/0 polypropylene
suture anastomoses. The sheep was weaned from
cardiopulmonary bypass, the mini-thoracotomy was
closed in layers and a chest drain was inserted.
Systemic pain medication, in the form of 2 mg
Morphine sulphate [Bodene (Pty) Ltd, trading as
Intramed, Port Elizabeth, SA] intramuscularly twice a
day and 5 mg Depomycin [INTERVET SA (Pty) Ltd,
Johannesburg, SA] daily as antibiotic, was adminis-
tered for 5 days post-operatively. Animals were
extubated 2–4 h post-operatively. Underwater drains
and pressure lines were removed before animals were
transferred to an overnight facility.
Results
In vitro study
Biomechanical testing
The following baseline mechanical results were obtained
in pulmonary homografts harvested within 6 h after
death. These samples were obtained from valves of
juvenile sheep from a local abattoir. The mean TS were
1.04 ± 0.36 MPa for the pulmonary wall and
1.24 ± 0.79 MPa for the pulmonary leaflet. The mean
TS for the pulmonary wall in the three ischemic groups
were as follows: (group 1: 1.03 ± 0.36 MPa; group 2:
0.95 ± 0.22 MPa; group 3: 1.16 ± 0.34 MPa). The
mean TS for the pulmonary leaflets in the three ischemic
groups were as follows: (group 1: 2.57 ± 1.07 MPa;
group 2: 2.93 ± 0.50 MPa; group 3: 3.03 ± 1.02 MPa).
The mean YM baseline value was 2.06 ± 0.77 MPa
for the pulmonary wall and 5.68 ± 4.57 MPa for the
pulmonary leaflet. The mean YM for the pulmonary wall
in the three ischemic groups were as follows: (group 1:
3.21 ± 0.90 MPa; group 2: 3.26 ± 0.93 MPa; group 3:
3.81 ± 1.31 MPa). The mean YM for the pulmonary
leaflets in the three ischemic groups were as follows:
(group 1: 9.93 ± 2.63 MPa; group 2: 9.25 ± 5.02 MPa;
group 3: 10.73 ± 4.33 MPa).
The mean Td baseline values were 70.57 ± 1.03 C
for the pulmonary wall and 67.16 ± 1.31 C for the
pulmonary leaflets. The mean Td for the pulmonary
wall in the three ischemic groups were as follows:
(group 1: 70.57 ± 1.12 C; group 2: 71.19 ± 1.13 C;
group 3: 72.44 ± 2.85 C). The mean Td for the
pulmonary leaflets in the three ischemic groups were as
follows: (group 1: 70.25 ± 0.76 C; group 2:
71.25 ± 1.17 C; group 3: 71.01 ± 0.36 C).
In vitro evaluation of the TS, YM and Td temperatures
did not reveal any statistically significant differences
(p[0.05) between the 24, 48 and 72 h groups.
Microbiological examinations
Microbiological examination detected that the initial
microbes present on the CPAs in the different groups
were as follows: group 1 (n = 5): no aerobic organisms
and 3 positive cultures for anaerobic microorganisms;
group 2 (n = 5): 2 positive samples for aerobic
organisms and 1 positive sample for anaerobic organ-
ism; group 3 (n = 5): 3 samples were positive for
aerobic microorganisms and 3 samples were positive
for anaerobic microorganisms. The most common
microorganisms were gram ? bacilli and coagulase
negative staphylococci. After 24 h of sterilization in
the nutrient antibiotic solution no organisms could be
cultured in the pre-cryopreserved specimens. No
fungal cultures were positive at any point in time.
Histological evaluation
The histological findings in the control group (har-
vested\6 h post-mortem) are described as reference.
H&E staining showed endothelial-like cells on the
surface of the control valves; however, a confluent
layer was not present in all of the specimens. The ECM
exhibited a normal configuration with an absence of
abnormalities in the collagen and elastin structures,
and this was confirmed with Picrosirius red staining.
The spindleform-shaped fibroblast-like cells were
arranged in a parallel layout; however, the number
of cells in some of the samples was limited. Endothe-
lial-like cells were confirmed to be endothelial cells by
positive expression of vWF and CD31. Interstitial
cells were confirmed to be myofibroblasts since these
cells were a-actin positive. No differences between the
groups were observed post processing and thawing,
compared to the control group.
Scanning electron microscopy
According to the modified Krs et al. (2006) and Smit,
PhD, unpublished data, 2011 classification, the
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baseline samples of the pulmonary leaflets were all in
category III (100 %) and, for the pulmonary wall
samples, 86.7 % were in category II and 13.3 % were
in category I. In group 1 (24 h), 12.5 % of the
pulmonary leaflets fell in category I, 37.5 % in
category II and 50 % in category III, while 96 % of
the pulmonary wall samples fell in category I and 4 %
in category II. In group 2 (48 h), 21.7 % of the
pulmonary leaflets fell in category I, 60.9 % in
category II and 17.4 % in category III, while 100 %
of the pulmonary wall samples fell in category I. In
group 3 (72 h), 18.2 % of the pulmonary leaflets fell in
category I, 40.9 % in category II and 40.9 % in
category III, while 100 % of the pulmonary wall
samples fell in category I.
No statistically significant differences (p[ 0.05) in
SEM was found between any of the three ischemic
groups.
Calcium content analysis
The mean baseline quantitative calcium content was
1.8 ± 0.09 lg/mg of dry weight for the pulmonary
leaflet samples and 0.80 ± 0.06 lg/mg of dry weight
for the pulmonary wall samples. Only the baseline
values of the control group (\6 h) were determined
and compared to the explanted tissues in the three
ischemic groups.
In vivo study
Echocardiography
Echocardiographic examinations showed limited mor-
phological calcification. The calcification was in the
range of none to mild for the valve leaflets in all the
groups. Mild to moderate calcification was observed in
the valve annulus and in the pulmonary wall. There
were however no differences between the groups.
The mean pressure gradients at the CPAs within the
different groups were 12.0 ± 5.6 mmHg in group 1,
10.7 ± 3.6 mmHg in group 2 and 10.5 ± 2.6 mmHg
in group 3 respectively. There were no statistically
significant differences between the groups (group 1 vs
2, p = 0.70; group 1 vs 3, p = 0.61; group 2 vs 3,
p = 0.94). The mean annulus diameter in group 1 was
20.2 ± 2.2 mm, in group 2 it was 20.4 ± 2.6 mm, and
in group 3 it was 20.5 ± 1.5 mm. The mean diameter
at the ST-junction was 18.4 ± 1.4 mm in group 1,
19.3 ± 1.5 mm in group 2 and 20.1 ± 2.1 mm in
group 3. The mean diameter of the pulmonary artery
was 20.2 ± 1.5 mm in group 1, 20.5 ± 1.3 mm in
group 2 and 20.5 ± 1.4 mm in group 3.
Serology samples
The mean total IgG for group 1 was 7.5 ± 8.9 kU/l,
for group 2, 7.3 ± 10.9 kU/l and for group 3,
37.0 ± 31.1 kU/l. The mean IgA and IgM values
were below 0.25 g/l for all three groups. There was no
obvious trend that would identify a marked immuno-
logical process in any specific group.
Gross examination
There was an absence of aneurysm formation, defor-
mations and thrombi in all of the explanted CPAs from
the three groups (Fig. 2). The leaflets were pliable
without fenestrations in all the samples from the three
groups (Fig. 3).
Biomechanical testing
The TS, YM and Td of the leaflets and wall specimens
are summarized in Table 1. No statistically significant
differences were found between groups, nor did they
differ from the baseline results. Certainly no loss of
strength could be demonstrated in any of the groups
compared to the baseline values.
Fig. 2 Explanted cryopreserved pulmonary homograft of
group 1 (24 h). Note the pliable leaflet after 150 days of
implantation in the juvenile sheep
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Histological evaluation
The histological examinations are presented in
Fig. 4a–c. In the H&E staining results there was
evidence that all samples from group 1 were covered
by a monolayer of endothelial-like cells. Acellularity
of the ECM in group 1 was between 30 and 90 %.
Eighty percent of the CPAs in group 2 were covered by
endothelial-like cells. The ECM was completely
acellular in 2 samples. The other CPAs in group 2
were between 0 and 90 % acellular. In group 3, all of
the CPAs were covered by a monolayer of endothelial-
like cells. Acellularity was found in one valve, whereas
the other valves were between 20 and 80 % acellular.
von Kossa staining detected severe calcification of a
leaflet in one of the explanted CPAs from group 3.
None of the other explanted CPAs showed calcifica-
tion of the leaflets. The pulmonary wall of only one of
the CPAs from group 1 showed mild calcification. In
group 2, there was severe wall calcification in two of
the CPAs, moderate calcification in two CPAs and no
calcification in one of the CPAs. Moderate calcifica-
tion was observed in the wall of one of the explanted
CPAs from group 3. None of the other explanted CPAs
in group 3 exhibited calcification. Picrosirius red
staining showed a well preserved ECM in all samples
from the three groups. Endothelial–like cells covering
the valve surfaces were identified as such since they
were vWF, CD31 and CD34 positive. Interstitial cells
were a-actin positive, however, since no CD4 positive
cells were found, none of the samples showed inflam-
matory cells within the ECM.
Scanning electron microscopy
After explantation, SEM was able to demonstrate that
88.0 % of the pulmonary leaflets from group 1 fell in
category III and 12.0 % fell in category II. In group 2,
62.7 % of the leaflets were classified as category III,
20.0 % as category II and 17.3 % as category I. In
group 3, 64.0 % of the leaflets fulfilled the criteria for
category III, 12.0 % for category II and 24.0 % for
category I.
In group 1, 37.3 % of the CPA pulmonary wall
specimens were classified as category III, 37.3 % as
category II, and 25.4 % as category I. In group 2,
26.7 % of the pulmonary wall specimens fulfilled the
criteria for category III, 37.3 % for category II and
36.0 % for category I. Finally, group 3 had 12.0 % of
pulmonary wall specimens in category III, 61.3 % in
category II and 26.7 % in category I.
Analysis of the SEM data for both the pulmonary
leaflet and wall showed a time-related change over the
categories (p\ 0.005 respectively). Although a gra-
dual deterioration in the endothelial covering of both
the pulmonary leaflets and walls in relation to the
ischemic time was observed, no differences in struc-
tural integrity could be demonstrated.
Calcium content analysis
Mean quantitative calcium content in the pulmonary
leaflets was 0.18 ± 0.13 lg/mg dry weight in group 1,
0.30 ± 0.57 lg/mg dry weight in group 2 and
0.05 ± 0.05 lg/mg dry weight in group 3. There is no
Fig. 3 Inverted cryopreserved pulmonary homograft (24 h)
after 150 days implantation
538 Cell Tissue Bank (2015) 16:531–544
123
difference between calcification in the explanted pul-
monary leaflets between the three groups (p = 0.518).
For the pulmonary wall the mean quantitative
calcium content was 16.12 ± 24.40 lg/mg dry weight
in group 1, 84.95 ± 16.07 lg/mg dry weight in group
2 and 68.11 ± 41.64 lg/mg dry weight in group 3.
The pulmonary wall calcification does not differ
between the groups (p = 0.218). Note that only one
pulmonary wall had significantly elevated calcium
content.
Discussion
The pulmonary homograft remains the gold standard
for right ventricle outflow tract (RVOT) reconstruc-
tion; its use is however limited by supply. The
worldwide practice of limiting homograft harvesting
to beating heart donors, or within 24 h post-mortem,
may contribute to this shortage. If post-mortem
harvesting times can be extended safely, thereby
allowing more time to obtain consent or fulfill other
legal requirements, cadaver-based donor programs
can be expanded or in some cases be re-opened. This
depends on whether viability of homografts con-
tributes significantly to attenuate homograft failure as
claimed by O’Brien et al. (1991). On the other hand
Mitchell et al. (1998) considers all homografts to be
eventually acellular and thus non-viable. It is thus
possible to view homografts as biological scaffolds.
If all homografts eventually become acellular and
function as a biological scaffold, for the purpose of
this experimental animal study, it was important to
firstly evaluate the impact of extending ischemic
harvesting times on the morphology, structural and
strength characteristics of homografts, and taking the
historical perspectives on homograft biology and
degeneration into consideration.
Secondly, valve function and outcomes of the
biological interactions post implantation were evaluat-
ed in vivo in a standard juvenile ovine model.
Long-term durability of CPAs has previously been
correlated with warm- and cold ischemic times. Cell
metabolism is unchanged if the cold ischemic time is
\24 h and the warm ischemic time is\12 h (Lang et al.
1994; Hu et al. 1989). O’Brien et al. (1991) stated that
Table 1 Cryopreserved pulmonary homograft structural integrity testing
Variable B6 h baseline (n = 20) 24 h group (n = 5) 48 h group (n = 5) 72 h group (n = 5) p values
Tensile strength
Mean 1.24 1.58 1.54 2.18 0.8882*
SD 0.79 0.93 0.19 0.67
Median 1.01 1.75 1.61 2.40
Minimum 0.25 0.62 1.29 1.40
Maximum 3.73 2.72 1.72 3.06
Young’s modulus
Mean 5.68 6.55 5.94 7.76 0.5820*
SD 4.57 4.71 1.65 2.60
Median 4.78 7.75 6.14 8.55
Minimum 0.84 1.42 3.98 4.01
Maximum 18.42 11.36 8.21 10.57
Thermal denaturation temperature (Td)
Mean 67.16 70.96 68.53 71.99 0.1697*
SD 1.31 1.40 0.36 1.98
Median 66.68 71.22 68.52 72.36
Minimum 66.1 68.63 68.03 69.71
Maximum 69.35 72.11 68.94 74.26
SD standard deviation, h hour
* p value for the time effect in a mixed model
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VARIABLE (24h, n=5) (48h, n=5)
(A) Group 1  (B) Group 2 (C) Group 3 
(72h, n=5)
1.  H&E
2.  Picrosirius Red
3.  α -actin
4.  vWF
5.  CD4
6.  CD31
7.  SEM
Fig. 4 Histological findings of explanted CPAs. a group 1
(24 h), b group 2 (48 h), and c group 3 (72 h). For each group; 1
H&E staining, 2 Picrosirius red staining, 3 a-actin staining, 4
vWF staining, 5 CD4 staining, 6 CD31 staining and 7 SEM.
[h hours, H&E Hematoxylin and eosin, vWF von Willebrand
factor, SEM scanning electron microscopy]
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long-term durability is dependent on the viability of a
homograft and therefore the CPA needed to be prepared
within 24 h post-mortem. There is, however, no defini-
tion of preferred warm and cold ischemic times. In the
literature, different homograft banks have customized
protocols for processing and cryopreservation of homo-
grafts. There are also variations in the ischemic time
between harvesting and cryopreservation.
Several studies have addressed homograft viability.
Yankah and Hetzer (1987) reported that only 24 % of
the endothelial cells survive after 2 h of exposure to
room temperature. Crescenzo et al. (1992) noted the
relationship between ischemic time and progression of
fibroblast cell damage, which is reversible with a
warm ischemic time of up to 12 h. However, a warm
ischemic time longer than 12 h will lead to apoptosis.
Fibroblast response to warm ischemic time is corre-
lated with morphometric measurements (St Louis et al.
1991; Brockbank and Bank 1987).
Significant decreases in freedom of reoperation in
the cryopreserved homografts compared to the 4 C
stored homografts were observed in medium term
studies. However, in a recent single-center study
including 1,022 patients, O’Brien et al. (2001) com-
pared 4 C stored homografts with viable cryopre-
served homografts. In this 29-year follow-up study the
viability of homografts progressively reduced, result-
ing in non-viability after a few days, regardless of
whether the homografts were cryopreserved or stored
in the refrigerator, and whether they were stored in a
balanced salt solution or a nutrient medium. Thus the
viable homograft theory did not survive the test of time.
Barrat-Boyes et al. (1987) conducted a long-term
follow-up study including 248 patients in which valve
incompetence was assessed. Significant freedom of
incompetence of antibiotic-sterilized aortic homografts
was found in 95 % after 5 years, 78 % after 10 years
and 42 % at 14 years. Harvesting time was\24 h in 147
donors, between 24 and 48 h in 88 donors and between
49 and 75 h in 7 donors. Harvesting time was not
recorded for 43 of the donors. A multivariate analysis
showed that advanced donor valve age C55 years (CI
1.12 ± 0.30; p = 0.0002), aortic root size[30 mm (CI
1.39 ± 0.41; p = 0.0007), and recipient age\15 years
(CI 2.03 ± 0.61; p = 0.0008) are independent risk
factors for homograft incompetence.
Langley et al. (1996) reported, based on a series of
249 patients, a freedom of reoperation of sub-coronary
implanted antibiotic sterilized valves with a warm
ischemic time of 24 h and cold ischemic time of a
maximum of 3 months. The freedom of reoperation of
the aortic valve was excellent with 49.7 ± 5.6 % at
20 years follow-up.
The mean warm ischemic time of homografts
prepared at the European Homograft Bank is \6 h.
However, due to post-mortem delay, the average cold
ischemic harvesting time is 24 h, up to a maximum of
36 h (Goffin et al. 1996). The clinical data of these
homografts, presented by Meyns et al. (2005) shows that
the ischemic time has no statistical influence on the
long-term durability of these homografts when implant-
ed into pediatric patients. Only non-anatomic position
(p = 0.001), smaller graft size (p\ 0.0001), younger
age (on square root scale, p\ 0.0001) and clamp time
(p = 0.01) remain as independent risk factors.
On the other hand, Tweddell et al. (2000) investi-
gated the longevity of homografts used to reconstruct
the RVOT in 205 patients with congenital heart
disease and a mean age of 6.9 ± 7.6 years (range
3 days to 48 years). Freedom from homograft failure
was 54 ± 7 % at 10 years follow-up. They found that
independent risk factors for homograft failure in a
multivariate analysis were younger age (p\ 0.001),
longer warm ischemic time (p\ 0.001), Z-value\2
(p = 0.03), and aortic homograft (p = 0.04).
Importantly, Kadoba et al. (1991) performed a study
of cryopreserved aortic homografts in a lamb model in
which the cold ischemic time was extended up to 48 h.
The 48 h group performed as well as the fresh and 24 h
groups. The authors concluded that expanding the pool
for homografts is feasible by increasing the cold
ischemic time. However, no specific tests or histo-
logical examinations were performed to systematically
evaluate the allograft scaffolds or the quality of the
valvular tissue as in the present study.
In the present in vitro study, we could demonstrate
the presence of endothelial cells in all groups.
However, no pattern was observed between the
presence of endothelial cells and cold ischemic
harvesting times. These findings suggest that the
number of endothelial and interstitial cells present in
the 72 h group were comparable with the number of
cells in the 24 and 48 h groups. Thus, if the presence of
endothelial cells was used to assess suitability, there
should be no limitation on increasing the cold
ischemic harvesting time. No testing was performed
to compare the viability of the different cell types in
this study as all samples were harvested after 24 h
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ischemic time. This 24 h period was conclusively
demonstrated in previous studies to be associated with
non-viability (Arminger 1995).
The in vivo part of this study showed that
implanted CPAs, from the different cold ischemic
harvesting time groups, exhibited intra-luminal cov-
erage with endothelial cells. These endothelial cells
are most probably of host origin since, at implanta-
tion, most of the endothelial cells were either no
longer present or non-viable after at least 24 h post-
mortem. However, additional investigation will be
required to confirm the origin of these endothelial
cells. Gradual loss of endothelial cells with prolonged
ischemic times might not be detrimental to the
clinical durability of the homograft, as the immune
response of the recipient to the implant is severely
diminished.
Previous studies have revealed that re-endothe-
lialization is commonly seen in the juvenile sheep
model (Dohmen et al. 2006a, b). This can however
not be generalized to humans, since this process
seems to be more restricted and takes longer in
humans (Dohmen et al. 2007; Konertz et al. 2011).
Further investigation is needed to better understand
the recellularization of decellularized heart valves
implanted into patients. The endothelial cells also
need to be investigated for their functionality, as
they have a major determinant function. Endotheli-
um normally inhibits thrombus formation and leuko-
cyte adhesion, regulates vasomotor function, and
inhibits smooth muscle cell proliferation. If there is
damage to the endothelium interaction with inflam-
matory cells and interstitial cells, by expression of
vascular adhesion, molecules such as VCAM-1,
ICAM-1 and ELAM-1 will change (Ardehali et al.
1995). The intercellular network via macrophages,
T-lymphocytes, endothelial cells and smooth muscle
cells is generated by a variety of stimulatory
cytokines (IL-1, IL-2, IL-6, and tumor necrosis
factor-a) and growth factors (PDGF, IGF-1, FGF,
HB-EGF, EGF, GM-CSF, and TGF-b) (Duquesnoy
and Demetris 1995). Therefore, it is of great interest
that autologous endothelial cells overgrow the CPAs
to restore the function of the interstitial cells and
decrease the activation of the inflammatory cells. On
the contrary, it is important to avoid a pseudo-intima
formation on the leaflet surface since this will lead to
leaflet retraction, resulting in central valve regurgi-
tation (Affonso da Costa et al. 2004). Pseudo-intima
formation was not observed in any of the implanted
valves in this study.
A well-known disadvantage of viable CPAs in
transplant surgery is that donor endothelial and
interstitial cells evoke an immune response from the
host (Jane-wit et al. 2013). Decellularization of a CPA
could attenuate the humoral immune response to
donor HLA after implantation of a CPA as was shown
by Kneib et al. (2012). Homografts with viable
endothelium and interstitial cells have a significantly
higher number of immunogenic epitopes, for HLA
classes I and II, than the decellularized groups exhibit,
and should therefore initiate a more dramatic immune
response from the recipient. In this study, with
harvesting times in excess of 24 h, endothelial
viability is highly unlikely.
On a cellular level there were no differences
between the groups with varying cold ischemic times.
The extracellular matrix was tested to evaluate if the
strength of the scaffold would change by extending the
cold ischemic harvesting time. No differences in
strength of the valve tissue were detected. Further-
more, there was no increase in tissue denaturation,
evaluated by measuring the Td, in any of the groups.
The extracellular matrix was also confirmed to be
intact by histological examination. From the in vitro
data we are able to conclude that tissue strength is
unaltered and therefore extending the cold ischemic
harvesting time is possible.
From the in vivo investigations, with a minimum
follow-up of 150 days in a juvenile sheep model,
hemodynamic data shows no differences between the
groups when the cold ischemic time was increased.
Furthermore, the histological examinations showed a
normal intact extracellular matrix. The immunohisto-
chemistry results in this study did not show any
differences in inflammatory reactions when cold
ischemic time was increased. An overgrowth of
endothelial cells was observed in all groups. There-
fore, in this study, there were no contra-indications to
extending the cold ischemic harvesting time in order to
increase the number of viable homografts.
Limitations
The limitations of this study are that data provided by
the juvenile sheep model cannot be unconditionally
applied to human patients, since re-endothelialization
is more extensive in this model than in humans. Also,
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the functionality and viability of the endothelial and
interstitial cells were not investigated in this study.
Conclusions
This experimental study supports the concept that,
with a limited warm ischemic time, the cold ischemic
harvesting time of cryopreserved homografts can be
prolonged. This could be a way to reduce homograft
shortage since by increasing time limits for harvesting,
the opportunities for obtaining consent and facilitating
cadaver donor programs are increased. However,
long-term clinical hemodynamic evaluation is needed
to confirm this approach.
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